Literature DB >> 18937655

Clinical features of cutaneous and disseminated cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Paraty, Rio de Janeiro.

Ricardo Vieira-Gonçalves1, Claude Pirmez, Maria Eugenia Jorge, Wilson Jacinto Silva Souza, Márcia Pereira Oliveira, Marcio S Rutowitsch, Alda Maria Da-Cruz.   

Abstract

BACKGROUND: American tegumentary leishmaniasis (ATL) caused by Leishmania (Viannia) braziliensis is endemic in Rio de Janeiro State (RJ), where the disease shows epidemiologic and clinical characteristics distinct from those of ATL in other Brazilian regions. Paraty is the second most important endemic area in RJ; however, reports on leishmaniasis in this region refer to the occurrence of the disease without describing its characteristics.
METHODS: The clinical features of 71 cases of ATL reported between 1991 and 1997 in Paraty are presented. Thirty patients were re-evaluated 10 years later.
RESULTS: Males and females were affected in similar proportions, and the disease was more prevalent in patients aged between 10 and 49 years (63.4%). Cutaneous leishmaniasis was the most prevalent clinical form observed. Unique lesions were present in 69% of cases, 91.6% of which displayed an ulcerated aspect. Although mucosal leishmaniasis was not observed, severe clinical manifestations, such as disseminated cutaneous lesions caused by L. braziliensis, were diagnosed in two patients. These patients presented skin lesions with different clinical aspects spread throughout the body, as well as low cellular immune responses. Montenegro skin test (92% positivity) and serology (8% IgM and 56% IgG anti-Leishmania positive results) were the most utilized tests for supporting the diagnosis of leishmaniasis. Parasites, detected in 27 of the 33 cases analyzed, were characterized as L. braziliensis.
CONCLUSION: ATL in Paraty shares the clinical and laboratory characteristics reported for ATL in other regions of RJ, probably because of the similar epidemiologic context related to the Atlantic rainforest region.

Entities:  

Mesh:

Year:  2008        PMID: 18937655     DOI: 10.1111/j.1365-4632.2008.03701.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

1.  Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions.

Authors:  C de Oliveira Mendes-Aguiar; R Vieira-Gonçalves; L H Guimarães; M P de Oliveira-Neto; E M Carvalho; A M Da-Cruz
Journal:  Clin Exp Immunol       Date:  2016-06-06       Impact factor: 4.330

2.  The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis.

Authors:  C de O Mendes-Aguiar; A Gomes-Silva; E Nunes; R Pereira-Carvalho; R S Nogueira; M de P Oliveira-Neto; A L Bertho; A M Da-Cruz
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

3.  Anti-leishmanial effects of purified compounds from aerial parts of Baccharis uncinella C. DC. (Asteraceae).

Authors:  Luiz Felipe D Passero; Alexis Bonfim-Melo; Carlos Eduardo P Corbett; Márcia D Laurenti; Marcos H Toyama; Daniela O de Toyama; Paulete Romoff; Oriana A Fávero; Simone S dos Grecco; Cynthia A Zalewsky; João Henrique G Lago
Journal:  Parasitol Res       Date:  2010-10-01       Impact factor: 2.289

Review 4.  Immunoregulation in human American leishmaniasis: balancing pathology and protection.

Authors:  K J Gollob; A G Viana; W O Dutra
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

5.  Nutritional status in patients with cutaneous leishmaniasis and a study of the effects of zinc supplementation together with antimony treatment.

Authors:  Miguel Guzman-Rivero; Ernesto Rojas; Aleida Verduguez-Orellana; Henry Pardo; Mary Cruz Torrico; Lieselotte Cloetens; Björn Akesson; Edgar Sejas
Journal:  Food Nutr Res       Date:  2014-11-06       Impact factor: 3.894

6.  American tegumentary leishmaniasis: an uncommon clinical and histopathological presentation.

Authors:  Adrilena Lopes Adriano; Paula Azevedo Borges Leal; Marcelle Parente Breckenfeld; Igor dos Santos Costa; Clarisse Almeida; Antônio Renê Diógenes de Sousa
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896

7.  Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.

Authors:  Hélio Galdino; Anetícia Eduarda Maldaner; Lívia Lara Pessoni; Frederico M Soriani; Ledice Inácia de Araújo Pereira; Sebastião Alves Pinto; Fernanda Bugalho Duarte; Clayson Moura Gomes; Anna Karoline Aguiar Fleuri; Miriam Leandro Dorta; Milton Adriano Pelli de Oliveira; Mauro Martins Teixeira; Aline Carvalho Batista; Leo A B Joosten; Leda Quercia Vieira; Fátima Ribeiro-Dias
Journal:  BMC Infect Dis       Date:  2014-05-09       Impact factor: 3.090

8.  Disseminated Leishmaniasis by Leishmania viannia Subgenus: A Series of 18 Cases in Southeastern Brazil.

Authors:  Sebastian Vernal; Natalia A De Paula; Ciro M Gomes; Ana Maria Roselino
Journal:  Open Forum Infect Dis       Date:  2016-01-13       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.